• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.86% Nasdaq Down 1.14%

    Arbutus Biopharma Corporation (ABUS)

    -NasdaqCM
    4.88 Down 0.29(5.61%) 12:15PM EDT - Nasdaq Real Time Price
    Prev Close:5.17
    Open:5.15
    Bid:4.86 x 1300
    Ask:4.91 x 300
    1y Target Est:13.80
    Beta:1.31893
    Earnings Date:May 4 - May 9 (Est.)
    Day's Range:4.83 - 5.16
    52wk Range:2.72 - 15.96
    Volume:128,724
    Avg Vol (3m):206,684
    Market Cap:266.57M
    P/E (ttm):N/A
    EPS (ttm):-1.62
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ABUS

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):17.06
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.65
    Quarterly EPS Est (Mar-16) :-0.39
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arbutus Biopharma Corporation, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of chronic hepatitis B (HBV) infections in Canada and the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback